Austin Health

Running trials

• Recruiting

  A Study of ARC-02 in B-cell NHL

  NCT07691606· Phase 1· Source

• Recruiting

  Specific and Novel Approaches to Care of Inflammatory Bowel Disease During Pregnancy: the PREGO Study

  NCT07916727· Source

• Recruiting

  Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma

  NCT07100730· Phase 3· Source

• Recruiting

  PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

  NCT06855329· Source

• Active, not recruiting

  Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)

  NCT06317051· Phase 3· Source

• Recruiting

  Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)

  NCT06441747· Phase 2· Source

• Not yet recruiting

  Electronic Capturing of Activities During REhabilitation for Upper Limb After Stroke

  NCT06527261· Source

• Recruiting

  Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors

  NCT05868174· Phase 1· Source

• Recruiting

  A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  NCT05716100· Phase 3· Source

• Active, not recruiting

  Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy

  NCT05840211· Phase 3· Source

• Active, not recruiting

  Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer

  NCT05694936· Phase 2· Source

• Recruiting

  Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)

  NCT04939935· Phase 3· Source

• Active, not recruiting

  Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

  NCT05243797· Phase 3· Source

• Recruiting

  The ElectRx Study - A Neurotechnology Approach to the Treatment of IBD

  NCT05469607· Source

• Active, not recruiting

  PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI

  NCT05154162· Phase 3· Source

• Active, not recruiting

  Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy

  NCT05796089· Phase 2· Source

• Recruiting

  Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease

  NCT05136222· Source

• Recruiting

  Adaptive RadioTherapy for OroPharynx Cancer

  NCT04901234· Phase 2· Source

• Active, not recruiting

  In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy

  NCT04343885· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Crohn's disease2 recruiting
• ALS (motor neurone disease)1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Follicular lymphoma1 recruiting
• Glioblastoma1 recruiting
• Head and neck cancer1 recruiting
• Hodgkin lymphoma1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• Kidney cancer1 recruiting
• Liver and biliary tract cancer1 recruiting
• Mantle cell lymphoma1 recruiting
• Stroke1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

  NCT07076550· Phase 1· Source

• Completed

  A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

  NCT06114745· Phase 1· Source

• Terminated

  The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

  NCT04876651· Phase 3· Source

• Completed

  Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

  NCT05255991· Phase 3· Source

• Recruiting

  Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

  NCT05523947· Phase 1/2· Source

• Recruiting

  Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults

  NCT04608630· Phase 2· Source

• Completed

  RegoNivo vs Standard of Care Chemotherapy in AGOC

  NCT04879368· Phase 3· Source

• Completed

  OLE of Phase 2b/3 Study ANAVEX2-73-AD-004

  NCT04314934· Phase 2/3· Source

• Completed

  Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer

  NCT03900884· Phase 1· Source